When a child is diagnosed with a serious genetic condition caused by a new genetic change (de novo mutation), parents often worry about the chances of this happening again in future pregnancies. Currently, the general recurrence risk given in clinic is a population average (usually ~1-2%). However, there is now a new strategy, called PREGCARE, that can refine this risk for each individual couple. This presentation will explore how it works, its potential benefits and what it means from a practitioner’s perspective.
The talk will be followed by drinks and nibbles until 7pm.